Copresentation of antigen and ligands of siglec-G induces B cell tolerance independent of CD22

Journal of Immunology

Volumn 191, Issue 4, 2013, Pages 1724-1731

  Pfrengle, Fabian ^a   Macauley, Matthew S ^a   Kawasaki, Norihito ^a   Paulson, James C ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; B LYMPHOCYTE RECEPTOR; CD22 ANTIGEN; LECTIN; LIGAND; LIPOSOME; NANOPARTICLE; SELF ANTIGEN; SIGLEC G; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTE SUBSETS; CALCIUM SIGNALING; DENDRITIC CELLS; GENE EXPRESSION REGULATION; GERMINAL CENTER; IMMUNE TOLERANCE; IMMUNOLOGIC MEMORY; LECTINS; LIGANDS; LIPOSOMES; LYMPHOPOIESIS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, TRANSGENIC; ORGAN SPECIFICITY; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; RECEPTORS, ANTIGEN, B-CELL; SIALIC ACID BINDING IG-LIKE LECTIN 2;

EID: 84881451966     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300921     Document Type: Article

References (43)

1. Reth, M. 1992. Antigen receptors on B lymphocytes. Annu. Rev. Immunol. 10: 97-121.
2. Ravetch, J. V., and L. L. Lanier. 2000. Immune inhibitory receptors. Science 290: 84-89.
3. Nitschke, L. 2009. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions. Immunol. Rev. 230: 128-143.
4. Jellusova, J., U. Wellmann, K. Amann, T. H. Winkler, and L. Nitschke. 2010. CD22 3 Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity. J. Immunol. 184: 3618-3627.
5. Crocker, P. R., J. C. Paulson, and A. Varki. 2007. Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7: 255-266.
6. Ding, C., Y. Liu, Y. Wang, B. K. Park, C. Y. Wang, P. Zheng, and Y. Liu. 2007. Siglecg limits the size of B1a B cell lineage by down-regulating NFkappaB activation. PLoS ONE 2: e997.
7. Hoffmann, A., S. Kerr, J. Jellusova, J. Zhang, F. Weisel, U. Wellmann, T. H. Winkler, B. Kneitz, P. R. Crocker, and L. Nitschke. 2007. Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population. Nat. Immunol. 8: 695-704.
8. O'Reilly, M. K., and J. C. Paulson. 2009. Siglecs as targets for therapy in immune-cell-mediated disease. Trends Pharmacol. Sci. 30: 240-248.
9. Jellusova, J., and L. Nitschke. 2011. Regulation of B cell functions by the sialic acid-binding receptors siglec-G and CD22. Front. Immunol. 2: 96.
10. Doody, G. M., L. B. Justement, C. C. Delibrias, R. J. Matthews, J. Lin, M. L. Thomas, and D. T. Fearon. 1995. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269: 242-244.
11. Smith, K. G., D. M. Tarlinton, G. M. Doody, M. L. Hibbs, and D. T. Fearon. 1998. Inhibition of the B cell by CD22: a requirement for Lyn. J. Exp. Med. 187: 807-811.
12. Whitney, G., S. Wang, H. Chang, K. Y. Cheng, P. Lu, X. D. Zhou, W. P. Yang, M. McKinnon, and M. Longphre. 2001. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33. Eur. J. Biochem. 268: 6083-6096.
13. Chen, G. Y., J. Tang, P. Zheng, and Y. Liu. 2009. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323: 1722-1725.
14. Chen, G. Y., X. Chen, S. King, K. A. Cavassani, J. Cheng, X. Zheng, H. Cao, H. Yu, J. Qu, D. Fang, et al. 2011. Amelioration of sepsis by inhibiting sialidasemediated disruption of the CD24-SiglecG interaction. Nat. Biotechnol. 29: 428-435.
15. Berland, R., and H. H. Wortis. 2002. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20: 253-300.
16. Martin, F., A. M. Oliver, and J. F. Kearney. 2001. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14: 617-629.
17. Duong, B. H., H. Tian, T. Ota, G. Completo, S. Han, J. L. Vela, M. Ota, M. Kubitz, N. Bovin, J. C. Paulson, and D. Nemazee. 2010. Decoration of Tindependent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo. J. Exp. Med. 207: 173-187.
18. Macauley, M. S., F. Pfrengle, C. Rademacher, C. M. Nycholat, A. J. Gale, A. von Drygalski, and J. C. Paulson. 2013. Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis. J. Clin. Invest. DOI: 10.1172/JCI69187.
19. Chen, W. C., N. Kawasaki, C. M. Nycholat, S. Han, J. Pilotte, P. R. Crocker, and J. C. Paulson. 2012. Antigen delivery to macrophages using liposomal nanoparticles targeting sialoadhesin/CD169. PLoS ONE 7: e39039.
20. Nycholat, C. M., C. Rademacher, N. Kawasaki, and J. C. Paulson. 2012. In silico-aided design of a glycan ligand of sialoadhesin for in vivo targeting of macrophages. J. Am. Chem. Soc. 134: 15696-15699.
21. Chen, W. C., G. C. Completo, D. S. Sigal, P. R. Crocker, A. Saven, and J. C. Paulson. 2010. In vivo targeting of B-cell lymphoma with glycan ligands of CD22. Blood 115: 4778-4786.
22. Collins, B. E., O. Blixt, S. Han, B. Duong, H. Li, J. K. Nathan, N. Bovin, and J. C. Paulson. 2006. High-affinity ligand probes of CD22 overcome the threshold set by cis ligands to allow for binding, endocytosis, and killing of B cells. J. Immunol. 177: 2994-3003.
23. Yu, H., H. Chokhawala, R. Karpel, H. Yu, B. Wu, J. Zhang, Y. Zhang, Q. Jia, and X. Chen. 2005. A multifunctional Pasteurella multocida sialyltransferase: a powerful tool for the synthesis of sialoside libraries. J. Am. Chem. Soc. 127: 17618-17619.
24. Haniuda, K., T. Nojima, K. Ohyama, and D. Kitamura. 2011. Tolerance induction of IgG+ memory B cells by T cell-independent type II antigens. J. Immunol. 186: 5620-5628.
25. Courtney, A. H., E. B. Puffer, J. K. Pontrello, Z. Q. Yang, and L. L. Kiessling. 2009. Sialylated multivalent antigens engage CD22 in trans and inhibit B cell activation. Proc. Natl. Acad. Sci. USA 106: 2500-2505.
26. Goodnow, C. C., J. Crosbie, S. Adelstein, T. B. Lavoie, S. J. Smith-Gill, R. A. Brink, H. Pritchard-Briscoe, J. S. Wotherspoon, R. H. Loblay, K. Raphael, et al. 2009. Altered immunoglobulin expression and functional silencing of selfreactive B lymphocytes in transgenic mice. J. Immunol. 183: 5442-5448.
27. Kitagawa, H., and J. C. Paulson. 1994. Differential expression of five sialyltransferase genes in human tissues. J. Biol. Chem. 269: 17872-17878.
28. Paulson, J. C., J. Weinstein, and A. Schauer. 1989. Tissue-specific expression of sialyltransferases. J. Biol. Chem. 264: 10931-10934.
29. Kono, M., Y. Ohyama, Y. C. Lee, T. Hamamoto, N. Kojima, and S. Tsuji. 1997. Mouse beta-galactoside alpha 2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression. Glycobiology 7: 469-479.
30. Ulloa, F., and F. X. Real. 2001. Differential distribution of sialic acid in alpha2,3 and alpha2,6 linkages in the apical membrane of cultured epithelial cells and tissues. J. Histochem. Cytochem. 49: 501-510.
31. Pillai, S., A. Cariappa, and S. T. Moran. 2004. Positive selection and lineage commitment during peripheral B-lymphocyte development. Immunol. Rev. 197: 206-218.
32. Nitschke, L., R. Carsetti, B. Ocker, G. Köhler, and M. C. Lamers. 1997. CD22 is a negative regulator of B-cell receptor signalling. Curr. Biol. 7: 133-143.
33. O'Keefe, T. L., G. T. Williams, S. L. Davies, and M. S. Neuberger. 1996. Hyperresponsive B cells in CD22-deficient mice. Science 274: 798-801.
34. Otipoby, K. L., K. B. Andersson, K. E. Draves, S. J. Klaus, A. G. Farr, J. D. Kerner, R. M. Perlmutter, C. L. Law, and E. A. Clark. 1996. CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 384: 634-637.
35. Sato, S., A. S. Miller, M. Inaoki, C. B. Bock, P. J. Jansen, M. L. Tang, and T. F. Tedder. 1996. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22- deficient mice. Immunity 5: 551-562.
36. Vos, Q., A. Lees, Z. Q. Wu, C. M. Snapper, and J. J. Mond. 2000. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol. Rev. 176: 154-170.
37. McHeyzer-Williams, L. J., and M. G. McHeyzer-Williams. 2005. Antigenspecific memory B cell development. Annu. Rev. Immunol. 23: 487-513.
38. Jellusova, J., S. Düber, E. Gückel, C. J. Binder, S. Weiss, R. Voll, and L. Nitschke. 2010. Siglec-G regulates B1 cell survival and selection. J. Immunol. 185: 3277-3284.
39. Tedder, T. F., J. C. Poe, and K. M. Haas. 2005. CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction. Adv. Immunol. 88: 1-50.
40. Poe, J. C., and T. F. Tedder. 2012. CD22 and Siglec-G in B cell function and tolerance. Trends Immunol. 33: 413-420.
41. Gross, A. J., J. R. Lyandres, A. K. Panigrahi, E. T. Prak, and A. L. DeFranco. 2009. Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance. J. Immunol. 182: 5382-5392.
42. Ferry, H., T. L. Crockford, K. Silver, N. Rust, C. C. Goodnow, and R. J. Cornall. 2005. Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lynand CD22-independent pathways affecting BCR regulation and B cell survival. Eur. J. Immunol. 35: 3655-3663.
43. Cornall, R. J., J. G. Cyster, M. L. Hibbs, A. R. Dunn, K. L. Otipoby, E. A. Clark, and C. C. Goodnow. 1998. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8: 497-508.